Cargando…
GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line
BACKGROUND: Pharmacological modulation of cell fate decisions and developmental gene regulatory networks holds promise for the treatment of heart failure. Compounds that target tissue-specific transcription factors could overcome non-specific effects of small molecules and lead to the regeneration o...
Autores principales: | Välimäki, Mika J., Leigh, Robert S., Kinnunen, Sini M., March, Alexander R., de Sande, Ana Hernández, Kinnunen, Matias, Varjosalo, Markku, Heinäniemi, Merja, Kaynak, Bogac L., Ruskoaho, Heikki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977156/ https://www.ncbi.nlm.nih.gov/pubmed/33736688 http://dx.doi.org/10.1186/s13287-021-02259-z |
Ejemplares similares
-
Nuclear Receptor-Like Structure and Interaction of Congenital Heart Disease-Associated Factors GATA4 and NKX2-5
por: Kinnunen, Sini, et al.
Publicado: (2015) -
GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes
por: Karhu, S. Tuuli, et al.
Publicado: (2020) -
Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds
por: Karhu, S. Tuuli, et al.
Publicado: (2018) -
Targeting GATA4 for cardiac repair
por: Välimäki, Mika J., et al.
Publicado: (2019) -
Synthesis, Identification,
and Structure–Activity
Relationship Analysis of GATA4 and NKX2-5 Protein–Protein
Interaction Modulators
por: Jumppanen, Mikael, et al.
Publicado: (2019)